Who are Bactrim or Macrobid's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bactrim-or-macrobid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Bactrim or Macrobid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bactrim or Macrobid (Bactrim or Macrobid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic (sulfonamide/trimethoprim combination for Bactrim; nitrofuran for Macrobid). Area: Infectious Disease.

marketed Antibiotic (sulfonamide/trimethoprim combination for Bactrim; nitrofuran for Macrobid) Dihydrofolate reductase (Bactrim); bacterial DNA and enzyme systems (Macrobid) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Bactrim or Macrobid (Bactrim or Macrobid) — Ohio State University. Bactrim (sulfamethoxazole-trimethoprim) and Macrobid (nitrofurantoin) are antibiotics that inhibit bacterial nucleotide synthesis and cell wall integrity, respectively, to kill or stop the growth of bacteria.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bactrim or Macrobid TARGET	Bactrim or Macrobid	Ohio State University	marketed	Antibiotic (sulfonamide/trimethoprim combination for Bactrim; nitrofuran for Macrobid)	Dihydrofolate reductase (Bactrim); bacterial DNA and enzyme systems (Macrobid)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic (sulfonamide/trimethoprim combination for Bactrim; nitrofuran for Macrobid) class)

Ohio State University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bactrim or Macrobid — Competitive Intelligence Brief. https://druglandscape.com/ci/bactrim-or-macrobid. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing